杏林製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2016/02/03 | 2,236 | 2,387 | 2,217 | 2,334 | +38 | +1.7% | 460,700 |
2016/02/02 | 2,237 | 2,310 | 2,237 | 2,296 | +25 | +1.1% | 138,700 |
2016/02/01 | 2,258 | 2,290 | 2,249 | 2,271 | +62 | +2.8% | 236,500 |
2016/01/29 | 2,203 | 2,226 | 2,144 | 2,209 | +3 | +0.1% | 303,400 |
2016/01/28 | 2,226 | 2,232 | 2,189 | 2,206 | -40 | -1.8% | 173,900 |
2016/01/27 | 2,236 | 2,256 | 2,212 | 2,246 | +38 | +1.7% | 144,700 |
2016/01/26 | 2,219 | 2,245 | 2,201 | 2,208 | -31 | -1.4% | 151,500 |
2016/01/25 | 2,239 | 2,264 | 2,209 | 2,239 | +31 | +1.4% | 178,600 |
2016/01/22 | 2,176 | 2,212 | 2,132 | 2,208 | +100 | +4.7% | 152,300 |
2016/01/21 | 2,163 | 2,205 | 2,108 | 2,108 | -59 | -2.7% | 172,700 |
2016/01/20 | 2,242 | 2,246 | 2,161 | 2,167 | -80 | -3.6% | 191,600 |
2016/01/19 | 2,252 | 2,287 | 2,236 | 2,247 | -17 | -0.8% | 188,700 |
2016/01/18 | 2,241 | 2,275 | 2,230 | 2,264 | -19 | -0.8% | 225,800 |
2016/01/15 | 2,317 | 2,330 | 2,268 | 2,283 | +8 | +0.4% | 149,100 |
2016/01/14 | 2,289 | 2,305 | 2,240 | 2,275 | -60 | -2.6% | 242,600 |
2016/01/13 | 2,325 | 2,346 | 2,292 | 2,335 | +34 | +1.5% | 177,700 |
2016/01/12 | 2,348 | 2,367 | 2,301 | 2,301 | -79 | -3.3% | 263,900 |
2016/01/08 | 2,376 | 2,428 | 2,328 | 2,380 | -23 | -1% | 253,500 |
2016/01/07 | 2,400 | 2,449 | 2,383 | 2,403 | -5 | -0.2% | 181,000 |
2016/01/06 | 2,440 | 2,471 | 2,379 | 2,408 | -30 | -1.2% | 347,200 |
2016/01/05 | 2,444 | 2,471 | 2,422 | 2,438 | -28 | -1.1% | 204,300 |
2016/01/04 | 2,543 | 2,593 | 2,463 | 2,466 | -66 | -2.6% | 219,200 |
2015/12/30 | 2,545 | 2,547 | 2,497 | 2,532 | -6 | -0.2% | 139,400 |
2015/12/29 | 2,499 | 2,549 | 2,471 | 2,538 | +54 | +2.2% | 160,700 |
2015/12/28 | 2,436 | 2,488 | 2,423 | 2,484 | +51 | +2.1% | 238,100 |
2015/12/25 | 2,443 | 2,479 | 2,420 | 2,433 | -6 | -0.2% | 233,600 |
2015/12/24 | 2,555 | 2,562 | 2,430 | 2,439 | -113 | -4.4% | 370,100 |
2015/12/22 | 2,592 | 2,594 | 2,544 | 2,552 | -12 | -0.5% | 216,800 |
2015/12/21 | 2,570 | 2,588 | 2,533 | 2,564 | -26 | -1% | 222,300 |
2015/12/18 | 2,600 | 2,662 | 2,578 | 2,590 | -39 | -1.5% | 561,800 |
2015/12/17 | 2,560 | 2,642 | 2,552 | 2,629 | +151 | +6.1% | 720,200 |
2015/12/16 | 2,547 | 2,586 | 2,440 | 2,478 | -21 | -0.8% | 803,400 |
2015/12/15 | 2,547 | 2,577 | 2,491 | 2,499 | -70 | -2.7% | 420,600 |
2015/12/14 | 2,509 | 2,573 | 2,461 | 2,569 | +58 | +2.3% | 620,200 |
2015/12/11 | 2,510 | 2,552 | 2,484 | 2,511 | +48 | +1.9% | 789,400 |
2015/12/10 | 2,520 | 2,535 | 2,435 | 2,463 | +233 | +10.4% | 1,338,000 |
2015/12/09 | 2,262 | 2,277 | 2,222 | 2,230 | -23 | -1% | 206,200 |
2015/12/08 | 2,304 | 2,318 | 2,248 | 2,253 | -34 | -1.5% | 203,600 |
2015/12/07 | 2,323 | 2,344 | 2,285 | 2,287 | ±0 | ±0% | 191,600 |
2015/12/04 | 2,290 | 2,295 | 2,238 | 2,287 | -51 | -2.2% | 289,100 |
2015/12/03 | 2,334 | 2,345 | 2,316 | 2,338 | -4 | -0.2% | 255,900 |
2015/12/02 | 2,306 | 2,346 | 2,270 | 2,342 | +24 | +1% | 285,300 |
2015/12/01 | 2,329 | 2,341 | 2,307 | 2,318 | -6 | -0.3% | 347,900 |
2015/11/30 | 2,382 | 2,382 | 2,320 | 2,324 | -57 | -2.4% | 375,400 |
2015/11/27 | 2,388 | 2,393 | 2,365 | 2,381 | ±0 | ±0% | 161,200 |
2015/11/26 | 2,390 | 2,420 | 2,379 | 2,381 | +14 | +0.6% | 273,300 |
2015/11/25 | 2,340 | 2,379 | 2,323 | 2,367 | +8 | +0.3% | 264,500 |
2015/11/24 | 2,353 | 2,372 | 2,333 | 2,359 | +18 | +0.8% | 213,600 |
2015/11/20 | 2,307 | 2,348 | 2,294 | 2,341 | +33 | +1.4% | 209,600 |
2015/11/19 | 2,341 | 2,345 | 2,296 | 2,308 | -9 | -0.4% | 265,800 |
2251~
2300
件表示中 / 3683件
類似銘柄と比較する
現在ご覧いただいている「杏林製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
杏林製薬 | 147,600円 | +3.2% | +4.5% | 3.52% | 16.96倍 | 0.65倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
ジーエヌアイ | 222,700円 | +21.7% | +999.9% | 0.00% | 9.27倍 | 3.07倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
持田薬 | 306,500円 | +3.0% | +27.5% | 2.61% | 19.40倍 | 0.84倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
栄研化 | 225,300円 | +0.4% | -8.4% | 2.35% | 28.92倍 | 1.64倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
ネクセラファーマ | 85,000円 | +22.8% | - | 0.00% | 69.44倍 | 1.12倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム